Kennichi Kakudo Selected Research

Kennichi Kakudo Research Topics

Disease

54	Neoplasms (Cancer) 12/2022 - 01/2002
24	Carcinoma (Carcinomatosis) 01/2022 - 06/2002
21	Breast Neoplasms (Breast Cancer) 12/2007 - 01/2002
14	Papillary Thyroid Cancer 01/2022 - 04/2003
13	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2003
11	Lymphatic Metastasis 11/2017 - 02/2003
10	Thyroiditis 01/2021 - 04/2005
9	Papillary Carcinoma 08/2018 - 11/2002
7	Neoplasm Metastasis (Metastasis) 12/2022 - 03/2002
7	Adenoma (Adenomas) 03/2021 - 11/2002
6	Fibrosis (Cirrhosis) 08/2012 - 09/2009
6	Lymphoma (Lymphomas) 10/2006 - 01/2003
5	Immunoglobulin G4-Related Disease 10/2020 - 09/2009
5	Adenocarcinoma 01/2019 - 10/2002
5	Hypothyroidism 08/2012 - 03/2010
5	Goiter 01/2012 - 11/2002
4	Follicular Adenocarcinoma 01/2022 - 01/2010
3	Anaplastic Thyroid Carcinoma 01/2022 - 01/2010
3	Inflammation (Inflammations) 10/2020 - 01/2007
2	Thyroid Nodule (Nodule, Thyroid) 06/2021 - 03/2021
2	Thyroid Diseases (Thyroid Disease) 01/2021 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2016 - 01/2005
2	Stomach Neoplasms (Stomach Cancer) 08/2012 - 06/2002
2	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 03/2010 - 09/2009
2	Subacute Thyroiditis (Thyroiditis, De Quervain) 09/2009 - 04/2005
2	Carcinogenesis 05/2006 - 11/2002
2	Medullary Carcinoma 06/2005 - 01/2005
2	Chronic Thyroiditis 03/2004 - 01/2004
2	Ductal Carcinoma 11/2002 - 01/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2021
1	Hyperthyroidism 06/2021
1	Graves Disease (Basedow Disease) 01/2021
1	Hashimoto Disease (Thyroiditis, Hashimoto) 10/2020
1	Drug-Related Side Effects and Adverse Reactions 10/2020

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin G (IgG)IBA 01/2021 - 09/2009
9	Proteins (Proteins, Gene)FDA Link 04/2015 - 11/2002
8	Messenger RNA (mRNA)IBA 04/2015 - 06/2002
6	Uridine Monophosphate (UMP)IBA 03/2021 - 01/2011
5	ParaffinIBA 02/2014 - 06/2002
4	RacivirIBA 01/2022 - 01/2010
4	IodineIBA 08/2021 - 01/2015
4	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 11/2018 - 04/2006
4	Thyroglobulin FDA Link 11/2017 - 09/2005
4	AntibodiesIBA 04/2011 - 06/2002
4	AcidsIBA 08/2009 - 01/2002
4	Vascular Endothelial Growth Factor DIBA 04/2006 - 02/2003
4	Estrogen ReceptorsIBA 11/2003 - 05/2002
4	RetinoidsIBA 04/2003 - 01/2002
3	Capsules (Microcapsules)IBA 12/2022 - 11/2002
3	Methotrexate (Mexate)FDA LinkGeneric 07/2021 - 01/2002
3	Monoclonal AntibodiesIBA 03/2020 - 01/2003
3	AutoantibodiesIBA 08/2012 - 04/2011
3	Biomarkers (Surrogate Marker)IBA 02/2006 - 07/2002
3	Vascular Endothelial Growth Factor CIBA 02/2006 - 04/2003
3	fragile histidine triad proteinIBA 09/2002 - 07/2002
3	Thymidine PhosphorylaseIBA 07/2002 - 01/2002
2	prolinedithiocarbamate (PDTC)IBA 01/2022 - 02/2014
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 04/2011
2	Immune Checkpoint InhibitorsIBA 05/2018 - 10/2017
2	Plasminogen Activators (Plasminogen Activator)IBA 11/2014 - 04/2006
2	Cadherins (E-Cadherin)IBA 08/2012 - 07/2010
2	Indicators and Reagents (Reagents)IBA 04/2011 - 10/2002
2	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2011 - 04/2003
2	Thyroid HormonesIBA 01/2010 - 09/2005
2	PeriostinIBA 01/2010 - 08/2009
2	Peptides (Polypeptides)IBA 08/2009 - 11/2006
2	AdrenomedullinIBA 08/2009 - 11/2006
2	Mitogen-Activated Protein KinasesIBA 12/2007 - 01/2007
2	Transcription Factors (Transcription Factor)IBA 05/2006 - 09/2003
2	NitratesIBA 04/2006 - 02/2006
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2006 - 07/2005
2	3-nitrotyrosineIBA 04/2006 - 02/2006
2	NitritesIBA 04/2006 - 02/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006 - 02/2006
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2005 - 03/2004
2	Carrier Proteins (Binding Protein)IBA 06/2005 - 09/2003
2	Calcium-Binding ProteinsIBA 01/2005 - 01/2004
2	Polo-Like Kinase 1IBA 01/2005 - 01/2004
2	VimentinIBA 04/2004 - 06/2002
2	EnzymesIBA 12/2003 - 06/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2003 - 11/2003
2	Hormones (Hormone)IBA 12/2003 - 03/2002
2	Cyclin-Dependent Kinase Inhibitor p27IBA 09/2003 - 06/2003
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 04/2003 - 02/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2003 - 03/2002
2	retinoic acid receptor betaIBA 11/2002 - 09/2002
2	Histidine (L-Histidine)FDA Link 07/2002 - 01/2002
2	Tamoxifen FDA LinkGeneric 02/2002 - 01/2002
2	Fluorouracil (Carac)FDA LinkGeneric 02/2002 - 01/2002
1	Codon (Codons)IBA 06/2021
1	Cyclic AMP (AMP, Cyclic)IBA 06/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2021
1	alectinibIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	CrizotinibIBA 01/2019

Therapy/Procedure

15	Therapeutics 01/2021 - 01/2002
10	Thyroidectomy 08/2021 - 04/2005
5	Drug Therapy (Chemotherapy) 01/2019 - 02/2002
1	Conservative Treatment 08/2021
1	Immunotherapy 10/2020